Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future

Alzheimer's and Dementia

Volumn 9, Issue 5, 2013, Pages 602-608

  Geda, Yonas E ^a   Schneider, Lon S ^b   Gitlin, Laura N ^c   Miller, David S ^d   Smith, Gwenn S ^e   Bell, Joanne ^f   Evans, Jovier ^g   Lee, Michael ^h   Porsteinsson, Anton ⁱ   Lanctôt, Krista L ^j,k   Rosenberg, Paul B ^e   Sultzer, David L ^l   Francis, Paul T ^m   Brodaty, Henry ⁿ   Padala, Prasad P ^o,p   Onyike, Chiadikaobi U ^e   Ortiz, Luis Agüera ^q,r   Ancoli Israel, Sonia ^s   Bliwise, Donald L ^t   Martin, Jennifer L ^l   Vitiello, Michael V ^u   Yaffe, Kristine ^v   Zee, Phyllis C ^w   Herrmann, Nathan ^j   Sweet, Robert A ^x,y   Ballard, Clive ^m   Khin, Ni A ^z   Alfaro, Cara ^z   Murray, Patrick S ^x,y   Schultz, Susan ^aa   Lyketsos, Constantine G ^e   more..

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Bracket   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^g NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^j Sunnybrook Health Sciences Centre   (Canada)

^k UNIVERSITY OF TORONTO   (Canada)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m KING'S COLLEGE LONDON   (United Kingdom)

ⁿ UNIVERSITY OF NEW SOUTH WALES   (Australia)

^o GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^p UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^q CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^r HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^s UNIVERSITY OF CALIFORNIA   (United States)

^t EMORY UNIVERSITY   (United States)

^u UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^v UNIVERSITY OF CALIFORNIA   (United States)

^w NORTHWESTERN UNIVERSITY   (United States)

^x UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^y VETERANS AFFAIRS MEDICAL CENTER   (United States)

^z CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^aa UNIVERSITY OF IOWA   (United States)

more..

Author keywords

Agitation aggression; Alzheimer's disease; Apathy; Behavioral and psychological symptoms of dementia; Delusions; Dementia; Depression; Hallucinations; Mild behavioral impairment; Mild cognitive impairment; Neuropsychiatric symptoms; Psychosis; Sleep disorders

Indexed keywords

AMYLOID;

AGITATION; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; APATHY; BASAL GANGLION; BEHAVIOR RATING SCALE FOR DEMENTIA OF THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMER DISEASE; BRAIN DAMAGE; BRIEF PSYCHIATRIC RATING SCALE; COGNITIVE DEFECT; DEPRESSION; EMOTIONAL STRESS; ENVIRONMENTAL FACTOR; FRONTAL CORTEX; GENETIC SUSCEPTIBILITY; HEREDITY; HIPPOCAMPUS; HUMAN; JEALOUS DELUSION; MEDICAL LITERATURE; MEDICAL RESEARCH; MENTAL DISEASE; MILD COGNITIVE IMPAIRMENT; MONOAMINERGIC SYSTEM; MULTIDIMENSIONAL OBSERVATION SCALE FOR ELDERLY SUBJECTS; NEUROBIOLOGY; NEUROPSYCHIATRIC INVENTORY; NEUROPSYCHIATRIC INVENTORY CLINICIAN RATING SCALE; NEUROPSYCHIATRIC INVENTORY QUESTIONNAIRE; PERIKARYON; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOGERIATRIC DEPENDENCY RATING SCALE; PSYCHOLOGICAL RATING SCALE; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; QUESTIONNAIRE; REVIEW; REVISED MEMORY AND BEHAVIOR PROBLEMS CHECKLIST; SLEEP; THALAMUS; THEORETICAL MODEL;

AGITATION/AGGRESSION; ALZHEIMER'S DISEASE; APATHY; BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA; DELUSIONS; DEMENTIA; DEPRESSION; HALLUCINATIONS; MILD BEHAVIORAL IMPAIRMENT; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHIATRIC SYMPTOMS; PSYCHOSIS; SLEEP DISORDERS;

ALZHEIMER DISEASE; HUMANS; MENTAL DISORDERS;

EID: 84883557180     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2012.12.001     Document Type: Article

References (68)

1. J.B. Martin The integration of neurology, psychiatry, and neuroscience in the 21st century Am J Psychiatry 159 2002 695 704 (Pubitemid 34465040)
2. B.H. Price, R.D. Adams, and J.T. Coyle Neurology and psychiatry: closing the great divide Neurology 54 2000 8 14 (Pubitemid 30038730)
3. A. Alzheimer Uber eine eigenartige erkrankung der hirnrinde Allgemeine Zeitschrift fur Psych Psychisch-Gerichtliche Medizin 64 1907 146 148
4. American Psychiatric Association American Psychiatric Association Task Force on DSM-IV Diagnostic and statistical manual of mental disorders: DSM-IV 4th ed. 1994 American Psychiatric Association Washington, DC
5. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944 (Pubitemid 14076461)
6. L.S. Schneider Organising the language of Alzheimer's disease in light of biomarkers Lancet Neurol 9 2010 1044 1045
7. B. Dubois, H.H. Feldman, C. Jacova, J.L. Cummings, S.T. Dekosky, and P. Barberger-Gateau Revising the definition of Alzheimer's disease: a new lexicon Lancet Neurol 9 2010 1118 1127
8. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, and A.M. Fagan Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 280 292
9. M.S. Albert, S.T. DeKosky, D. Dickson, B. Dubois, H.H. Feldman, and N.C. Fox The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 270 279
10. G.M. McKhann, D.S. Knopman, H. Chertkow, B.T. Hyman, C.R. Jack Jr., and C.H. Kawas The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 263 269
11. M.M. Mesulam From sensation to cognition Brain 121 1998 1013 1052
12. C.G. Lyketsos, M.C. Carrillo, J.M. Ryan, A.S. Khachaturian, P. Trzepacz, and J. Amatniek Neuropsychiatric symptoms in Alzheimer's disease Alzheimers Dement 7 2011 532 539
13. C.G. Lyketsos, J.M. Sheppard, M. Steinberg, J.A. Tschanz, M.C. Norton, and D.C. Steffens Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study [see comments.] Int J Geriatr Psychiatry 16 2001 1043 1053 (Pubitemid 33089268)
14. G.S. Alexopoulos, R.C. Abrams, R.C. Young, and C.A. Shamoian Cornell scale for depression in dementia Biol Psychiatry 23 1988 271 284 (Pubitemid 18047596)
15. R.S. Marin Apathy: a neuropsychiatric syndrome J Neuropsychiatry Clin Neurosci 3 1991 243 254
16. J. Cohen-Mansfield, P. Werner, and M.S. Marx An observational study of agitation in agitated nursing home residents Int Psychogeriatr 1 1989 153 165
17. R.E. Wragg, and D.V. Jeste Overview of depression and psychosis in Alzheimer's disease Am J Psychiatry 146 1989 577 587 (Pubitemid 19121278)
18. J.C. Morris, S. Edland, C. Clark, D. Galasko, E. Koss, and R. Mohs The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43 1993 2457 2465 (Pubitemid 24004527)
19. S.S. Mirra, A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, and L.M. Brownlee The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 41 1991 479 486
20. J.E. Overall, and D.R. Gorham The Brief Psychiatric Rating Scale Psychol Rep 10 1962 799 812
21. I.M. Wilkinson, and J. Graham-White Psychogeriatric dependency rating scales (PGDRS): a method of assessment for use by nurses Br J Psychiatry 137 1980 558 565 (Pubitemid 11251324)
22. E. Helmes, K.G. Csapo, and J.A. Short Standardization and validation of the Multidimensional Observation Scale for Elderly Subjects (MOSES) J Gerontol 42 1987 395 405 (Pubitemid 17103781)
23. L. Teri, P. Truax, R. Logsdon, J. Uomoto, S. Zarit, and P.P. Vitaliano Assessment of behavioral problems in dementia: the revised memory and behavior problems checklist Psychol Aging 7 1992 622 631
24. J.L. Cummings, M. Mega, K. Gray, S. Rosenberg-Thompson, D.A. Carusi, and J. Gornbein The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia Neurology 44 1994 2308 2314 (Pubitemid 24382728)
25. R. Black, B. Greenberg, J.M. Ryan, H. Posner, J. Seeburger, and J. Amatniek Scales as outcome measures for Alzheimer's disease Alzheimers Dement 5 2009 324 339
26. J.T. Olin, L.S. Fox, S. Pawluczyk, N.A. Taggart, and L.S. Schneider A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer disease Am J Geriatr Psychiatry 9 2001 400 405 (Pubitemid 33015127)
27. P.P. De Deyn, K. Rabheru, A. Rasmussen, J.P. Bocksberger, P.L. Dautzenberg, and S. Eriksson A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia Neurology 53 1999 946 955 (Pubitemid 29442108)
28. D. Paleacu, Y. Barak, I. Mirecky, and D. Mazeh Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study Int J Geriatr Psychiatry 23 2008 393 400 (Pubitemid 351566336)
29. P.N. Tariot, P.R. Solomon, J.C. Morris, P. Kershaw, S. Lilienfeld, and C. Ding A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group Neurology 54 2000 2269 2276
30. L.S. Schneider, P.N. Tariot, K.S. Dagerman, S.M. Davis, J.K. Hsiao, and M.S. Ismail Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease N Engl J Med 355 2006 1525 1538 (Pubitemid 44547805)
31. T.J. Hwang, D.L. Masterman, F. Ortiz, L.A. Fairbanks, and J.L. Cummings Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms Alzheimer Dis Assoc Disord 18 2004 17 21 (Pubitemid 38325891)
32. E. Kokmen, Y. Ozsarfati, C.M. Beard, P.C. O'Brien, and W.A. Rocca Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease J Clin Epidemiol 49 1996 79 83 (Pubitemid 26089553)
33. D. Tsuang, W. Kukull, L. Sheppard, R.L. Barnhart, E. Peskind, and S.D. Edland Impact of sample selection on APOE epsilon 4 allele frequency: a comparison of two Alzheimer's disease samples J Am Geriatr Soc 44 1996 704 707
34. C.G. Lyketsos, O. Lopez, B. Jones, A.L. Fitzpatrick, J. Breitner, and S. DeKosky Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the Cardiovascular Health Study JAMA 288 2002 1475 1483
35. Y.E. Geda, R.O. Roberts, D.S. Knopman, R.C. Petersen, T.J. Christianson, and V.S. Pankratz Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study Arch Gen Psychiatry 65 2008 1193 1198
36. K. Palmer, F. Di Iulio, A.E. Varsi, W. Gianni, G. Sancesario, and C. Caltagirone Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer's disease: the role of depression and apathy J Alzheimers Dis 20 2010 175 183
37. D.I. Kaufer, J.L. Cummings, P. Ketchel, V. Smith, A. MacMillan, and T. Shelley Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory J Neuropsychiatry Clin Neurosci 12 2000 233 239 (Pubitemid 30303778)
38. J.C. Morris, S. Weintraub, H.C. Chui, J. Cummings, C. Decarli, and S. Ferris The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers Alzheimer Dis Assoc Disord 20 2006 210 216 (Pubitemid 44900933)
39. K. de Medeiros, P. Robert, S. Gauthier, F. Stella, A. Politis, and J. Leoutsakos The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia Int Psychogeriatr 22 2010 984 994
40. H.R. Kranzler, R.M. Kadden, T.F. Babor, and B.J. Rounsaville Longitudinal, expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders J Nerv Ment Dis 182 1994 277 283 (Pubitemid 24185726)
41. R.G. Robinson, R.E. Jorge, K. Clarence-Smith, and S. Starkstein Double-blind treatment of apathy in patients with poststroke depression using nefiracetam J Neuropsychiatry Clin Neurosci 21 2009 144 151
42. G.S. Alexopoulos, B.S. Meyers, R.C. Young, S. Campbell, D. Silbersweig, and M. Charlson 'Vascular depression' hypothesis Arch Gen Psychiatry 54 1997 915 922 (Pubitemid 128719702)
43. G.S. Alexopoulos The vascular depression hypothesis: 10 years later Biol Psychiatry 60 2006 1304 1305 (Pubitemid 44838542)
44. G.S. Zubenko, J. Moossy, and U. Kopp Neurochemical correlates of major depression in primary dementia Arch Neurol 47 1990 209 214 (Pubitemid 20058120)
45. G.E. Alexander, M.D. Crutcher, and M.R. DeLong Basal ganglia- thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions Prog Brain Res 85 1990 119 146
46. J.L. Cummings Frontal-subcortical circuits and human behavior Arch Neurol 50 1993 873 880 (Pubitemid 23229317)
47. E.E. Benarroch Basic neurosciences with clinical applications 2006 Butterworth Heinemann/Elsevier Philadelphia
48. N. Geschwind, and E. Kaplan A human cerebral deconnection syndrome. A preliminary report Neurology 12 1962 675 685
49. M.M. Mesulam Principles of behavioral neurology 1985 F.A. Davis Philadelphia
50. M.M. Mesulam Behavioral neuroanatomy: Large-scale networks, association cortex, frontal syndromes, the limbic system, and hemispheric specializations Principles of behavioral and cognitive neurology 2nd ed. 2000 Oxford University Press New York p. 1-120
51. M.M. Mesulam Large-scale neurocognitive networks and distributed processing for attention, language, and memory Ann Neurol 28 1990 597 613
52. G.S. Smith, E. Kramer, C. Hermann, Y. Ma, V. Dhawan, and T. Chaly Serotonin modulation of cerebral glucose metabolism in depressed older adults Biol Psychiatry 66 2009 259 266
53. G.S. Smith, E. Kramer, Y. Ma, C.R. Hermann, V. Dhawan, and T. Chaly Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease Brain 132 2009 392 401
54. D.L. Sultzer, C.V. Brown, M.A. Mandelkern, M.E. Mahler, M.F. Mendez, and S.T. Chen Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease Am J Psychiatry 160 2003 341 349 (Pubitemid 41110461)
55. S. Reeves, R. Brown, R. Howard, and P. Grasby Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease Neurology 72 2009 528 534
56. G.A. Marshall, L. Monserratt, D. Harwood, M. Mandelkern, J.L. Cummings, and D.L. Sultzer Positron emission tomography metabolic correlates of apathy in Alzheimer disease Arch Neurol 64 2007 1015 1020 (Pubitemid 47048003)
57. G.S. Smith, F.M. Gunning-Dixon, F.E. Lotrich, W.D. Taylor, and J.D. Evans Translational research in late-life mood disorders: implications for future intervention and prevention research Neuropsychopharmacology 32 2007 1857 1875 (Pubitemid 47258525)
58. R.A. Sweet, B.G. Pollock, D.L. Sukonick, B.H. Mulsant, J. Rosen, and W.E. Klunk The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer disease Int Psychogeriatr 13 2001 401 409 (Pubitemid 34326969)
59. M.A. DeMichele-Sweet, and R.A. Sweet Genetics of psychosis in Alzheimer's disease: a review J Alzheimers Dis 19 2010 761 780
60. W.E. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist, and D.P. Holt Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B Ann Neurol 55 2004 306 319 (Pubitemid 38269583)
61. M.A. Butters, W.E. Klunk, C.A. Mathis, J.C. Price, S.K. Ziolko, and J.A. Hoge Imaging Alzheimer pathology in late-life depression with PET and Pittsburgh Compound-B Alzheimer Dis Assoc Disord 22 2008 261 268
62. A.F. Jorm, C.M. Van Duijn, V. Chandra, L. Fratiglioni, A.B. Graves, and A. Heyman Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group Int J Epidemiol 20 1991 S43 S47
63. Y.E. Geda, D.S. Knopman, D.A. Mrazek, G.A. Jicha, G.E. Smith, and S. Negash Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study Arch Neurol 63 2006 435 440
64. R.M. Sapolsky Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders Arch Gen Psychiatry 57 2000 925 935
65. L.N. Gitlin, L. Winter, M.P. Dennis, N. Hodgson, and W.W. Hauck Targeting and managing behavioral symptoms in individuals with dementia: a randomized trial of a nonpharmacological intervention J Am Geriatr Soc 58 2010 1465 1474
66. L. Ayalon, A.M. Gum, L. Feliciano, and P.A. Arean Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review Arch Intern Med 166 2006 2182 2188 (Pubitemid 44748764)
67. L. Teri, L.E. Gibbons, S.M. McCurry, R.G. Logsdon, D.M. Buchner, and W.E. Barlow Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial JAMA 290 2003 2015 2022 (Pubitemid 37430584)
68. J. Cohen-Mansfield Nonpharmacological interventions for persons with dementia Alzheimers Care Today 6 2005 129 145